|
|
|
40
|
A591AH
|
DOXOTHER 50MG SOLN FOR INJ (TPP/AHI) DOXORUBICIN
|
DOXORUBICIN
|
DOXOTHER
|
50ML VIAL
|
BQ
|
18.46
|
18.46
|
SOLUTION FOR
|
0
|
VIAL
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
A591AM
|
DOXORUBICIN 2MG/ML SOLN FOR INJ (CHC)
|
DOXORUBICIN
|
DOXORUBICIN
|
5ML
|
BQ
|
30.66
|
30.66
|
VIAL
|
0
|
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
2026-03-05
|
|
|
|
40
|
A6219
|
TRANEXAMIC ACID 500MG TAB (REM/SBI)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
2x10
|
BQ
|
14.76
|
0.74
|
TABLET
|
0
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
A6219
|
TRANEXAMIC ACID 500MG TAB (REM) (BQ)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
2x10
|
BQ
|
11.96
|
0.598
|
TAB
|
30
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
42
|
A6219
|
TRANEXAMIC ACID 500MG TAB (REM)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
2x10
|
B
|
11.96
|
0.60
|
TAB
|
30
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
40
|
A621D
|
PAUSE 500MG TAB (EMC/COL) TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
PAUSE
|
30'S
|
BQ
|
14.27
|
0.48
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
A621D
|
PAUSE 500MG TAB (EMC) TRANEXAMIC ACID (BQ)
|
TRANEXAMIC ACID
|
PAUSE
|
30'S
|
BQ
|
17.67
|
0.589
|
TAB
|
30
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
40
|
A622A
|
TRANEXAMIC ACID 100MG/ML INJ (SLS/AHI)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
25X5ML
|
BQ
|
76.74
|
3.07
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2022-04-01
|
2022-06-30
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-03-29
|
|
|
|
41
|
A622A
|
TRANEXAMIC ACID 100MG/ML INJ (SLS) (BQ)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
25X5ML
|
BQ
|
63.72
|
2.5487
|
VIAL
|
15
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
40
|
A622B
|
TRANEXAMIC ACID 100MG/ML INJ (MON/PHA)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
5X5ML
|
BQ
|
9.79
|
1.96
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
42
|
A622B
|
TRANEXAMIC ACID 100MG/ML INJ (MON)
|
TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
5X5ML
|
BQ
|
7.50
|
1.50
|
AMPG
|
15
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
42
|
A622F
|
TRAMIC 100MG/ML INJ (JLP) TRANEXAMIC ACID
|
TRANEXAMIC ACID
|
TRAMIC
|
50X5ML
|
BQ
|
51.65
|
1.03
|
AMPG
|
15
|
AMP
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2028
|
ANTIHEMORRHAGIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTIHEMORRHAGIC AGENTS
|
|
|
|
|
40
|
A6611
|
IMIGRAN 100MG TAB (GSK/COL) SUMATRIPTAN
|
SUMATRIPTAN
|
IMIGRAN
|
2'S
|
C
|
49.47
|
24.74
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
283228
|
SELECTIVE SEROTONIN AGONIST
|
2022-04-01
|
2022-05-31
|
Delete from contract
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-04-19
|
|
|
|
40
|
A6612
|
IMIGRAN 50MG TAB (GSK/COL) SUMATRIPTAN
|
SUMATRIPTAN
|
IMIGRAN
|
2'S
|
C
|
33.92
|
16.96
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
283228
|
SELECTIVE SEROTONIN AGONIST
|
2022-04-01
|
2022-05-31
|
Delete from contract
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-04-19
|
|
|
|
40
|
A6614
|
MAXALT 10MG TAB (MSD/STO) RIZATRIPTAN
|
RIZATRIPTAN
|
MAXALT
|
6'S
|
C
|
49.91
|
8.32
|
TABLET
|
0
|
TAB
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
283228
|
SELECTIVE SEROTONIN AGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A6614
|
MAXALT 10MG TAB (MSD) RIZATRIPTAN (C)
|
RIZATRIPTAN
|
MAXALT
|
6'S
|
C
|
50.4
|
8.3996
|
TAB
|
14
|
BOX
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
283228
|
SELECTIVE SEROTONIN AGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN AGONIST
|
|
|
|
|
42
|
A6614
|
MAXALT 10MG TAB (MSD) RIZATRIPTAN
|
RIZATRIPTAN
|
MAXALT
|
6'S
|
C
|
50.40
|
8.40
|
TAB
|
14
|
BLIS
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
283228
|
SELECTIVE SEROTONIN AGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN AGONIST
|
|
|
|
|
42
|
A661AS
|
APO-ELETRIPTAN 40MG TAB (APO)
|
ELETRIPTAN HYDROBROMIDE
|
APO-ELETRIPTAN
|
6'S
|
C
|
22.18
|
3.70
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
283228
|
SELECTIVE SEROTONIN AGONIST
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN AGONIST
|
|
|
|
|
40
|
A661AX
|
SUMATRIPTAN 100MG TAB (DRL/AHI)
|
SUMATRIPTAN
|
SUMATRIPTAN
|
27'S
|
C
|
34.44
|
1.28
|
TABLET
|
0
|
TAB
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283228
|
SELECTIVE SEROTONIN AGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A661AY
|
APO-SUMATRIPTAN 50MG TAB (APO) (C)
|
SUMATRIPTAN
|
APO-SUMATRIPTAN
|
6'S
|
C
|
4.54
|
0.7566
|
TAB
|
0
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283228
|
SELECTIVE SEROTONIN AGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN AGONIST
|
|
